{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T18:34:32Z","timestamp":1758393272821,"version":"3.38.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bulcan.2024.07.007","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T20:48:12Z","timestamp":1741121292000},"page":"316-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Y a-t-il une place pour la fimbriectomie radicale prophylactique suivie d\u2019une ovariectomie diff\u00e9r\u00e9e\u00a0?"],"prefix":"10.1016","volume":"112","author":[{"given":"Tom","family":"Fidlers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Narducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Pasquesoone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Hudry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Mailliez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Becourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aicha Ben","family":"Miled","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Mart\u00ednez","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2024.07.007_bib0260","unstructured":"Defossez G, Le Guyader-Peyrou S, Uhry Z, Grosclaude P, Colonna M, Dantony E, et al. Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990\u00a0et 2018\u00a0\u2013\u00a0volume 1\u00a0: tumeurs solides\u00a0: \u00e9tude \u00e0 partir des registres des cancers du r\u00e9seau Francim [Internet]. 2019 [cited 2024\u00a0May 10]. Available from: https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/cancers\/cancer-du-sein\/documents\/rapport-synthese\/estimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-france-metropolitaine-entre-1990-et-2018-volume-1-tumeurs-solides-etud."},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.007_bib0265","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36\u00a0cancers in 185\u00a0countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bulcan.2024.07.007_bib0270","doi-asserted-by":"crossref","unstructured":"Cowppli-Bony A, Uhry Z, Remontet L, Voirin N, Monnereau A, Bouvier AM, et al. Survie des personnes atteintes de cancer en France m\u00e9tropolitaine 1989\u20132013 \u2013\u00a0partie 1\u00a0\u2013 tumeurs solides. [Internet]. 2016 [cited 2024\u00a0May 10]. Available from: https:\/\/www.santepubliquefrance.fr\/docs\/survie-des-personnes-atteintes-de-cancer-en-france-metropolitaine-1989-2013.-etude-a-partir-des-registres-des-cancers-du-reseau-francim.-partie-1.","DOI":"10.1016\/j.respe.2016.06.084"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.007_bib0275","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO clinical practice guideline","volume":"34","author":"Sessa","year":"2023","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.007_bib0280","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1200\/JCO.22.01549","article-title":"Overall survival with maintenance olaparib at a 7-year follow-up in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: the SOLO1\/GOG 3004\u00a0trial","volume":"41","author":"DiSilvestro","year":"2023","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.007_bib0285","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol"},{"issue":"23","key":"10.1016\/j.bulcan.2024.07.007_bib0290","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1\u00a0and BRCA2\u00a0mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.bulcan.2024.07.007_bib0295","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1136\/ijgc-2020-001556","article-title":"Ovarian cancer predisposition beyond BRCA1\u00a0and BRCA2\u00a0genes","volume":"30","author":"Pietragalla","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.007_bib0300","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/jmedgenet-2013-102015","article-title":"Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants","volume":"51","author":"Jervis","year":"2014","journal-title":"J Med Genet"},{"key":"10.1016\/j.bulcan.2024.07.007_bib0305","doi-asserted-by":"crossref","unstructured":"Ledermann J.A., Raja F.A., Fotopoulou C., Gonzalez-Martin A., Colombo N., Sessa C. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24(suppl 6):vi24-v32. doi : 10.1093\/annonc\/mdt333. [Erratum in: Ann Oncol. 2018 Oct 1;29(Suppl 4):iv259. doi: 10.1093\/annonc\/mdy157. PMID: 24078660]","DOI":"10.1093\/annonc\/mdt333"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.007_bib0310","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.bulcan.2024.07.007_bib0315","unstructured":"INCa. Synth\u00e8se\u00a0\u2013\u00a0femmes porteuses d\u2019une mutation de BRCA1\u00a0ou BRCA2\/D\u00e9tection pr\u00e9coce du cancer du sein et des annexes et strat\u00e9gies de r\u00e9duction du risque. Collection recommandations et r\u00e9f\u00e9rentiels [Internet]. 2017 [cited 2024\u00a0May 21]. Available from: https:\/\/www.e-cancer.fr\/Professionnels-de-sante\/Recommandations-et-outils-d-aide-a-la-pratique\/Oncogenetique-ou-Cancers-avec-predispositions-genetiques."},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.007_bib0320","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.007_bib0325","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2018.11.033","article-title":"The fallopian tube, \u201cprecursor escape\u201d and narrowing the knowledge gap to the origins of high-grade serous carcinoma","volume":"152","author":"Soong","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.bulcan.2024.07.007_bib0330","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/1471-0528.14543","article-title":"Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review","volume":"124","author":"Chen","year":"2017","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.007_bib0335","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.007_bib0340","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2015.09.018","article-title":"Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): a comprehensive review","volume":"139","author":"Patrono","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.bulcan.2024.07.007_bib0345","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.clon.2018.03.036","article-title":"Outcome and prognostic impact of surgical staging in serous tubal intraepithelial carcinoma: a cohort study and systematic review","volume":"30","author":"Van der Hoeven","year":"2018","journal-title":"Clin Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.007_bib0350","doi-asserted-by":"crossref","first-page":"pky061","DOI":"10.1093\/jncics\/pky061","article-title":"Population frequency of serous tubal intraepithelial carcinoma (STIC) in clinical practice using SEE-Fim protocol","volume":"2","author":"Samimi","year":"2018","journal-title":"JNCI Cancer Spectr"},{"issue":"13","key":"10.1016\/j.bulcan.2024.07.007_bib0355","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1200\/JCO.2016.69.9330","article-title":"Evidence of stage shift in women diagnosed with ovarian cancer during phase II of the United Kingdom familial ovarian cancer screening study","volume":"35","author":"Rosenthal","year":"2017","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.bulcan.2024.07.007_bib0360","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1158\/1078-0432.CCR-15-2750","article-title":"Early detection of ovarian cancer using the risk of ovarian cancer algorithm with frequent CA125\u00a0testing in women at increased familial risk\u00a0\u2013\u00a0combined results from two screening trials","volume":"23","author":"Skates","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"21","key":"10.1016\/j.bulcan.2024.07.007_bib0365","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1\u00a0or BRCA2\u00a0mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.bulcan.2024.07.007_bib0370","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.bulcan.2024.07.007_bib0375","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1\u00a0or BRCA2\u00a0mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.bulcan.2024.07.007_bib0380","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1\u00a0or BRCA2\u00a0mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.007_bib0385","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bulcan.2024.07.007_bib0390","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bpobgyn.2022.03.001","article-title":"The surgical menopause","volume":"81","author":"Pillay","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.007_bib0395","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.AOG.0000167394.38215.56","article-title":"Ovarian conservation at the time of hysterectomy for benign disease","volume":"106","author":"Parker","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.007_bib0400","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/1471-0528.16424","article-title":"Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study","volume":"128","author":"Gaba","year":"2021","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.bulcan.2024.07.007_bib0405","doi-asserted-by":"crossref","first-page":"e1361","DOI":"10.1016\/j.clbc.2018.07.015","article-title":"Satisfaction and impact on quality of life of clinical and instrumental surveillance and prophylactic surgery in BRCA-mutation carriers","volume":"18","author":"D\u2019Alonzo","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.bulcan.2024.07.007_bib0410","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejca.2021.02.007","article-title":"Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy","volume":"148","author":"Michaelson-Cohen","year":"2021","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.bulcan.2024.07.007_bib0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2021.06.070","article-title":"Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1\u00a0and BRCA2\u00a0mutations","volume":"225","author":"Smith","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.007_bib0420","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.maturitas.2010.03.018","article-title":"Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1\/2\u00a0mutation carriers","volume":"66","author":"Kenkhuis","year":"2010","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.007_bib0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.03.023","article-title":"Risk of complication at the time of laparoscopic hysterectomy: a prediction model built from the National Surgical Quality Improvement Program database","volume":"223","author":"Pepin","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.bulcan.2024.07.007_bib0430","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1245\/s10434-023-13630-0","article-title":"Postoperative outcomes after staged versus coordinated breast surgery and bilateral salpingo-oophorectomy","volume":"30","author":"Vemuru","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.007_bib0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.06.004","article-title":"Persistence of fimbrial tissue on the ovarian surface after salpingectomy","volume":"217","author":"Gan","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.007_bib0440","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ygyno.2011.02.012","article-title":"Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1\u00a0or 2\u00a0genes? Rationale and preliminary development","volume":"121","author":"Leblanc","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"28","key":"10.1016\/j.bulcan.2024.07.007_bib0445","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","article-title":"Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer","volume":"23","author":"Madalinska","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2024.07.007_bib0450","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2019.04.055","article-title":"WISP: A prospective, multi-center trial of salpingectomy with delayed oophorectomy versus risk reducing salpingo-oophorectomy in women at increased risk for hereditary ovarian cancer","volume":"154","author":"Lu","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.07.007_bib0455","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3390\/cancers15041141","article-title":"Prophylactic radical fimbriectomy with delayed oophorectomy in women with a high risk of developing an ovarian carcinoma: results of a prospective national pilot study","volume":"15","author":"Leblanc","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.bulcan.2024.07.007_bib0460","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/ijgc-2023-004377","article-title":"TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol","volume":"33","author":"Steenbeek","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bulcan.2024.07.007_bib0465","article-title":"Identifier NCT04251052, A non randomized prospective clinical trial comparing the non-inferiority of salpingectomy to salpingo-oophorectomy to reduce the risk of ovarian cancer among BRCA1 carriers [SOROCk]","year":"2020","journal-title":"ClinicalTrials.gov [Internet]"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.007_bib0470","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/ijgc-2020-001541","article-title":"Preventing ovarian cancer through early excision of tubes and late ovarian removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial","volume":"31","author":"Gaba","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.bulcan.2024.07.007_bib0475","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses\u2019 health study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bulcan.2024.07.007_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","volume":"107","author":"Falconer","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.007_bib0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2018.10.016","article-title":"Menopausal symptoms and surgical complications after opportunistic bilateral salpingectomy, a register-based cohort study","volume":"220","author":"Collins","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.07.007_bib0490","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO\u2013ESMO\u2013ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease","volume":"35","author":"Ledermann","year":"2024","journal-title":"Ann Oncol"},{"issue":"2019","key":"10.1016\/j.bulcan.2024.07.007_bib0495","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2019.04.054","article-title":"Worry and regret in the prospective multicentre TUBA study in mutation carriers","volume":"154","author":"Steenbeek","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.007_bib0500","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ygyno.2018.05.011","article-title":"Age-specific ovarian cancer risks among women with a BRCA1\u00a0or BRCA2\u00a0mutation","volume":"150","author":"Kotsopoulos","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2024.07.007_bib0505","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41416-019-0446-1","article-title":"International trends in the uptake of cancer risk reduction strategies in women with a BRCA1\u00a0or BRCA2\u00a0mutation","volume":"121","author":"Metcalfe","year":"2019","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.bulcan.2024.07.007_bib0255","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.fertnstert.2013.01.109","article-title":"Frequency of premature menopause in women who carry a BRCA1\u00a0or BRCA2\u00a0mutation","volume":"99","author":"Finch","year":"2013","journal-title":"Fertil Steril"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455124002820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455124002820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T21:14:09Z","timestamp":1741122849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455124002820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0007455124002820"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2024.07.007","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Y a-t-il une place pour la fimbriectomie radicale prophylactique suivie d\u2019une ovariectomie diff\u00e9r\u00e9e\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2024.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}